new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
The recent plugin update to QIAGEN CLC Genomics version 21 (v21) includes new tools and database acc...
The Summer release of HGMD Professional is now available. Containing over 323,661 expert-curated ...
On Thursday, May 20, join us for the Every Lab Summit, a free virtual event exploring how any lab, a...
When a family has a child with a rare undiagnosed condition, a woman is diagnosed with an aggressi...
COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the world's largest and most comprehensive ...
Learn what’s new in the latest update to QIAGEN CLC Genomics version 21
Announcing the 2021.2 Release of HGMD® Professional
Interested in offering precision oncology testing in your lab?
Quality over quantity: Why national reference labs trust HGMD Professional
5 reasons why you should use COSMIC to identify cancer mutations
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients